|
Market Closed -
Euronext Paris
19:55:00 07/09/2026 +04
|
Pre-market 09:05:01 | |||
| 13.58 EUR | -1.45% |
|
13.57 | -0.07% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENFIT | Other Biotechnology & Medical Research | -1.45% | -3.96% | +157.93% | +294.54% | +291.35% | 790M |  |  | |
- Stock Market
- Stocks
- GNFT Stock
- Charts GENFIT
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
